Capital Advisors Ltd’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2
Closed 1619
2024
Q4
$0 Hold
2
﹤0.01% 1613
2024
Q3
$0 Hold
2
﹤0.01% 1639
2024
Q2
$0 Hold
2
﹤0.01% 1675
2024
Q1
$0 Hold
2
﹤0.01% 1580
2023
Q4
$0 Buy
+2
New +$67 ﹤0.01% 1521

Other funds holding ASTH

Capital Advisors Ltd's ASTH Position: Q1 2025 in Review

Capital Advisors Ltd sold out of Astrana Health (ASTH) in Q1 2025, closing a stake of 2 shares.

Capital Advisors Ltd first reported a position in ASTH in Q4 2023 and held it in 5 quarters. The position peaked at $0 in Q4 2024. 168 funds tracked by Wall St. Rank hold ASTH as of Q1 2025.

  • Capital Advisors Ltd reported no remaining Astrana Health position as of Q1 2025 after selling out during the quarter.
  • Capital Advisors Ltd sold 2 Astrana Health shares in Q1 2025.
  • Capital Advisors Ltd first reported a position in Astrana Health in Q4 2023 and held it in 5 quarters.
  • Capital Advisors Ltd's Astrana Health position peaked at $0 in Q4 2024.
  • 168 funds tracked by Wall St. Rank held Astrana Health as of Q1 2025.

Based on Capital Advisors Ltd's 13F filing for Q1 2025, filed 15 Apr 2025.